Advertisement
UK markets closed
  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     
  • FTSE 250

    19,824.16
    +222.18 (+1.13%)
     
  • AIM

    755.28
    +2.16 (+0.29%)
     
  • GBP/EUR

    1.1674
    +0.0017 (+0.15%)
     
  • GBP/USD

    1.2480
    -0.0031 (-0.25%)
     
  • Bitcoin GBP

    50,890.87
    -405.98 (-0.79%)
     
  • CMC Crypto 200

    1,322.08
    -74.46 (-5.33%)
     
  • S&P 500

    5,103.28
    +54.86 (+1.09%)
     
  • DOW

    38,256.23
    +170.43 (+0.45%)
     
  • CRUDE OIL

    84.07
    +0.50 (+0.60%)
     
  • GOLD FUTURES

    2,347.80
    +5.30 (+0.23%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,161.01
    +243.73 (+1.36%)
     
  • CAC 40

    8,088.24
    +71.59 (+0.89%)
     

U.S. senate calls hearing in Anheuser-Busch InBev mega beer deal

WASHINGTON, Nov 30 (Reuters) - Anheuser-Busch InBev's bid to buy its biggest rival, SABMiller (Xetra: BRW1.DE - news) , will be the subject of a U.S (Other OTC: UBGXF - news) . Senate hearing next week, the Senate Judiciary Committee said on Monday.

AB InBev, whose takeover of SABMiller would be one of the largest mergers in corporate history, formally announced early in November that it would buy SABMiller for $106 billion. It also said that it agreed to sell the latter's stake in U.S. venture MillerCoors to help win regulatory approval.

The hearing will be held by the Judiciary Committee's antitrust subcommittee on Dec. 8, the committee said in a brief statement.

The witnesses will be AB InBev chief executive Carlos Brito, Molson Coors CEO Mark Hunter, J. Wilson (Oslo: WILS.OL - news) of the Iowa Brewers Guild and Diana Moss, president of the American Antitrust Institute, said Conn Carroll, spokesman for Senator Mike Lee, chairman of the subcommittee.

The merger, if completed, will combine AB InBev's Budweiser, Stella Artois and Corona brands with SABMiller's Peroni, Grolsch and Pilsner Urquell and brew almost a third of the world's beer, dwarfing rivals Heineken (Other OTC: HEINY - news) and Carlsberg (Other OTC: CABGY - news) . (Reporting by Diane Bartz; Editing by Alan Crosby)